Stories &

Impact of Reduced Pulsatility on End-organs with Continuous Flow LVAD Support by Prof Christopher Hayward & A/Prof Kavitha Muthiah

Heart failure affects a significant portion of the Australian population, with an estimated 325,000 patients grappling with this condition.  Among these patients, those with refractory heart failure often find relief in continuous flow left ventricular assist devices (cfLVADs) as a bridge to transplantation.  Globally, over 25,000 individuals have been supported with cfLVADs, with implantation rates surpassing 3,000 patients annually and continuing to rise.  However, while these devices offer a lifeline, they come with their own set of challenges.